Healthcare · NIFTY 500

Caplin Point Laboratories Limited

NSECAPLIPOINT BSE524742 ISININE475E01026 SeriesEQ Listed on NSE · BSE

₹2,386.30 -134.00 (-5.32%) Updated 12 Nov, 8:49 pm IST

Open chart Back to screener

Price, daily close+19.41% in a year

Today

Open: ₹2,541.00
Prev close: ₹2,520.30
Day high: ₹2,564.00
Day low: ₹2,370.70
Volume: 4.61 L
Value traded: ₹112.72 Cr
Upper circuit: ₹3,024.30
Lower circuit: ₹2,016.30
52W high: ₹2,990.00
52W low: ₹1,500.30
1 month: -6.52%
6 months: +28.55%

52W low52W high

Ratios

Key numbers

Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.

Market cap₹18,136 Cr

P/E (TTM)27.34

P/B5.06

Book value / share₹471.90

EPS (TTM)₹87.28

ROE18.6%

Dividend yield0.34%

Dividend (12m)₹8.00 / share

Net margin (TTM)29.1%

Operating margin35.0%

Debt / equity0.00

Current ratio6.70

EV / EBITDA22.65

Sales growth (YoY qtr)+19.63%

Profit growth (YoY qtr)+15.78%

Sales CAGR 3Y+14.25%

Profit CAGR 3Y+19.45%

Shares7.60 Cr

Quarterly results

Results for each quarter

Last 12 quarters, consolidated, ₹ crore. Hover a bar to see the number.

Revenue and net profit

410115

Sep 23

436117

Dec 23

453122

Mar 24

459124

Jun 24

483131

Sep 24

493139

Dec 24

502141

Mar 25

510153

Jun 25

534154

Sep 25

543164

Dec 25

600170

Mar 26

610177

Jun 26

Revenue · QoQ (vs last quarter)

—+6.2%+4.1%+1.3%+5.3%+2.0%+1.9%+1.5%+4.7%+1.6%+11%+1.7%

Revenue · YoY (vs a year ago)

————+18%+13%+11%+11%+11%+10%+19%+20%

Net profit · QoQ (vs last quarter)

—+2.0%+3.7%+2.0%+5.5%+6.2%+1.3%+8.5%+1.1%+6.1%+3.8%+4.0%

Net profit · YoY (vs a year ago)

————+14%+19%+16%+23%+18%+18%+21%+16%

RevenueNet profitLine = trend

15.06

Sep 23

15.39

Dec 23

15.90

Mar 24

16.24

Jun 24

17.12

Sep 24

18.19

Dec 24

18.69

Mar 25

20.03

Jun 25

20.25

Sep 25

21.51

Dec 25

22.31

Mar 26

23.21

Jun 26

EPS (₹) · YoY (vs a year ago)

————+14%+18%+18%+23%+18%+18%+19%+16%

EPS (₹)Line = trend

₹ Cr	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25	Dec 25	Mar 26	Jun 26
Revenue	410	436	453	459	483	493	502	510	534	543	600	610
Other income	20.4	17.2	17.3	18.6	20.8	31.4	25.7	23.1	30.4	33.7	28.4	33.6
Total income	430	453	471	478	504	524	528	533	564	576	629	644
Raw material	66.8	51.0	57.9	63.7	69.2	59.8	60.8	73.5	92.3	89.2	102	107
Purchases	129	180	122	74.5	122	139	139	114	122	128	209	196
Employee cost	35.1	36.7	36.8	40.2	44.3	46.8	46.5	43.2	47.2	49.8	52.6	54.1
Other expenses	73.5	66.4	79.9	81.5	85.2	88.6	86.7	94.1	87.3	88.2	98.3	97.6
Total expenses	285	307	325	323	335	347	352	349	363	373	415	419
Operating profit	137	142	145	152	165	162	168	178	189	190	204	213
OPM %	33.5%	32.7%	32.1%	33.1%	34.1%	32.9%	33.4%	34.8%	35.4%	34.9%	34.0%	35.0%
Finance cost	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.2
Depreciation	11.8	13.9	16.4	16.0	16.8	16.2	17.0	16.3	18.4	19.3	18.8	21.6
Exceptional items	—	—	0.1	—	—	—	—	—	—	—	—	—
Profit before tax	146	145	146	154	169	177	177	184	201	204	213	225
Tax	29.9	25.6	24.8	29.5	37.7	37.2	31.4	33.7	40.8	38.0	40.6	46.1
Net profit	116	120	121	125	131	140	145	151	160	166	173	179
Profit to shareholders	115	117	122	124	131	139	141	153	154	164	170	177
EPS (₹)	15.06	15.39	15.90	16.24	17.12	18.19	18.69	20.03	20.25	21.51	22.31	23.21

Profit & loss

Results for each year

8 financial years (April to March), consolidated, ₹ crore.

Sales, operating profit and net profit

540195145

FY18

863260215

FY20

1,061329242

FY21

1,269395308

FY22

1,467441376

FY23

1,694552457

FY24

1,937647563

FY25

2,187761641

FY26

Revenue · YoY (vs a year ago)

——+23%+20%+16%+16%+14%+13%

Net profit · YoY (vs a year ago)

——+13%+27%+22%+21%+23%+14%

RevenueOperating profitNet profitLine = trend

₹ Cr	FY18	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	540	863	1,061	1,269	1,467	1,694	1,937	2,187
Other income	12.7	41.3	23.5	38.8	56.0	66.9	96.4	116
Total expenses	364	635	771	922	1,071	1,197	1,357	1,500
Employee cost	39.1	67.8	103	115	137	144	178	199
Operating profit	195	260	329	395	441	552	647	761
OPM %	36.1%	30.1%	31.0%	31.1%	30.1%	32.6%	33.4%	34.8%
Finance cost	0.1	0.3	1.6	0.7	0.8	0.8	0.6	0.9
Depreciation	19.0	31.6	37.0	46.9	45.0	53.4	66.0	72.8
Profit before tax	188	269	314	386	451	564	677	803
Tax	43.7	54.4	62.2	77.4	74.4	103	136	153
Tax rate %	23.2%	20.2%	19.8%	20.1%	16.5%	18.3%	20.0%	19.1%
Net profit	145	215	251	308	377	461	541	650
Profit to shareholders	145	215	242	—	376	457	563	641
Net margin %	26.8%	24.9%	22.8%	24.3%	25.7%	27.0%	29.1%	29.3%
EPS (₹)	19.16	28.20	31.71	39.26	49.18	59.90	70.25	84.11

Balance sheet

Assets and debt

At each year end (and the latest half year), ₹ crore.

Equity, debt and assets

1,8803.4178

Mar 23

2,3161.2139

Mar 24

2,8500.6199

Mar 25

3,5860.694.2

Mar 26

Shareholders' equity · YoY (vs a year ago)

—+23%+23%+26%

Shareholders' equityBorrowingsCashLine = trend

₹ Cr	Mar 23	Mar 24	Mar 25	Mar 26
Shareholders' equity	1,880	2,316	2,850	3,586
Long-term borrowings	0.0	0.9	0.0	0.0
Short-term borrowings	3.4	0.3	0.6	0.6
Total borrowings	3.4	1.2	0.6	0.6
Current liabilities	268	331	306	386
Fixed assets (PPE)	267	439	530	547
Inventories	288	363	336	429
Trade receivables	394	543	632	826
Cash & equivalents	178	139	199	94.2
Current assets	1,554	1,892	2,134	2,586
Total assets	2,191	2,697	3,209	4,045
Debt / equity	0.00	0.00	0.00	0.00

Cash flow

Cash coming in and going out

For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.

Operating, investing and financing cash

337-271-40.7

FY22

272-218-28.2

FY23

311-313-38.1

FY24

432-335-38.3

FY25

523-582-46.5

FY26

Operations · YoY (vs a year ago)

—-19%+14%+39%+21%

OperationsInvestingFinancingLine = trend

₹ Cr	FY22	FY23	FY24	FY25	FY26
Cash from operations	337	272	311	432	523
Cash from investing	-271	-218	-313	-335	-582
Cash from financing	-40.7	-28.2	-38.1	-38.3	-46.5
Spent on fixed assets	-91.2	-194	-146	-192	-248
Free cash flow	246	77.9	165	241	275
Net cash flow	25.1	25.6	-39.7	59.3	-106

Shareholding

Who holds the shares

Promoter and public holding at each quarter end, as filed with NSE.

Holding over time

70.6%Dec 23

70.6%Mar 24

70.6%Jun 24

70.6%Sep 24

70.6%Dec 24

70.6%Mar 25

70.6%Jun 25

70.6%Sep 25

70.6%Dec 25

70.6%Mar 26

70.6%Jun 26

70.6%Sep 26

Promoter & groupPublic

Latest (30 Sep 2026)

70.6%promoter

Promoter & group: 70.57%
Public (FIIs, mutual funds, retail…): 29.43%
Promoter change, last quarter: 0.00 pts

Dividends & news

Latest dividends and announcements

Dividends & corporate actions

Dividend - Rs 4 Per ShareEx 18-Sep-2026
Interim Dividend - Rs 4 Per ShareEx 29-May-2026
Dividend - Rs 3 Per ShareEx 12-Sep-2025
Interim Dividend - Rs 3 Per ShareEx 30-May-2025
Dividend - Rs 2.50 Per ShareEx 23-Sep-2024
Annual General MeetingEx 23-Sep-2024
Interim Dividend - Rs 2.50 Per ShareEx 31-May-2024
Annual General Meeting/Dividend - Rs 2.50 Per ShareEx 14-Sep-2023

Board meetings

CAPLIN POINT LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to inter-alia consider and approve the Unau…12-Nov-2026
the financial results for the period ended September 30, 202612-Nov-2026
the financial results for the period ended June 30, 2026 and to recommend final dividend12-Aug-2026
the Quarterly Unaudited Financial results of the Company for the period ended June 2026 and Dividend.12-Aug-2026
the financial results for the period ended March 31, 2026 and declaration of dividend, if any.14-May-2026

Filings with NSE

Analysts/Institutional Investor Meet/Con. Call Updates12 Nov
Investor Presentation12 Nov
Outcome of Board Meeting12 Nov
Analysts/Institutional Investor Meet/Con. Call Updates2 Nov
Certificate under SEBI (Depositories and Participants) Regulations, 20187 Oct
Trading Window28 Sep
Shareholders meeting25 Sep

Latest news

Caplin Point Q2 results: Revenue rises 18%, margin edges up; stock falls over 6%CNBC TV18 · 12 Nov, 1:54 pm Earnings call transcript: Caplin Point Q2 2026 shares fall as growth stays strong By Investing.comInvesting.com India · 12 Nov, 6:04 pm Caplin Point net profit up 13.8% to ₹182 crore in Q2FY27scanx.trade · 12 Nov, 1:34 pm Caplin Point Laboratories Ltd. Peer Comparison – Compare with OthersValue Research · 31 Aug, 6:59 pm Caplin Point Laboratories shares falls 2% post 10 observations from USFDAMoneycontrol.com · 24 Aug, 12:30 pm Caplin Point Laboratories Share Price Fall and ValuationUnivest · 9 Oct, 12:30 pm Caplin Point Q2 FY27 slides: 18% revenue growth, US doubles salesInvesting.com · 12 Nov, 6:41 pm Caplin Point Lab jumps over 20% in five daysBusiness Standard · 10 Jun, 12:30 pm

About

About Caplin Point Laboratories Limited

Caplin Point Laboratories Limited is listed on the NSE under the symbol CAPLIPOINT and belongs to the Healthcare sector.

Company details

Company name: Caplin Point Laboratories Limited
NSE symbol: CAPLIPOINT
BSE scrip code: 524742
ISIN: INE475E01026
Listed on: NSE, BSE
Series: EQ (normal equity)
Listed on NSE since: 23 Jun 2014
Face value: ₹2 per share
Market lot: 1 share
Shares issued: 7.60 crore
Index: NIFTY 500
Sector (NSE): Healthcare
Industry: Pharmaceuticals: Major
Managing director / CEO: Sridhar Ganesan
Chair: C. C. Paarthipan
Headquarters: Chennai, Tamil Nadu, India
Registered address: Ashvich Towers, 3rd Floor, No.3, Developed Plots, Industrial Estate, Perungudi, Chennai, Tamil Nadu 600096
Founded: 1990
Employees: 5,455
Financial year: April to March
Results basis: Consolidated
Website: caplinpoint.net

Peers

Other Healthcare stocks

Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.

India, Wall Street, crypto and commodities, live.

Every product, one clear workflow.

Built from data, on the record.

A clearer view of the markets.

Calculators and tools that show the maths.

Read the numbers, not the noise.

Caplin Point Laboratories Limited

Today

Ratios

Quarterly results

Revenue and net profit

Profit & loss

Sales, operating profit and net profit

Balance sheet

Equity, debt and assets

Cash flow

Operating, investing and financing cash

Shareholding

Holding over time

Latest (30 Sep 2026)

Dividends & news

Dividends & corporate actions

Board meetings

Filings with NSE

Latest news

About

Company details

Peers